Is an automated online clinical care pathway for people with genital chlamydia (chlamydia OCCP) within an eSexual health clinic feasible and acceptable? A proof of concept study.

Claudia S Estcourt; Jo Gibbs; Lorna J Sutcliffe; Voula  Gkatzidou; Laura Tickle; Kate Hone; Catherine Aicken; C Lowndes; Emma M Harding-Esch; Sue Eaton; Pippa Oakeshott; Ala Szczepura; Richard E Ashcroft; G. Hogan; Anthony Nettleship; D Pinson; SD Sadiq; Pam Sonnenberg

doi:10.1136/sextrans-2015-052270.153

Is an automated online clinical care pathway for people with genital chlamydia (chlamydia OCCP) within an eSexual health clinic feasible and acceptable? A proof of concept study.

Claudia S Estcourt, Jo Gibbs, Lorna J Sutcliffe, Voula Gkatzidou, Laura Tickle, Kate Hone, Catherine Aicken, C Lowndes, Emma M Harding-Esch, Sue Eaton, Pippa Oakeshott, Ala Szczepura, Richard E Ashcroft, G. Hogan, Anthony Nettleship, D Pinson, SD Sadiq, Pam Sonnenberg

Research output: Contribution to journal › Article › peer-review

Abstract

Introduction UK health strategy supports self- and internet-based care. Within the eSTI2 consortium (www.esti2.org.uk) we developed UK’s first automated Online Clinical Care Pathway for people with genital chlamydia (Chlamydia-OCCP) within an eSexual Health Clinic (eSHC). Chlamydia-OCCP includes: STI results service; clinical consultation; electronic prescription via community pharmacy; partner notification (PN); with integral telephone helpline support. It complies with regulatory, professional, prescribing and surveillance requirements. We report on a study to assess Chlamydia-OCCP feasibility and acceptability as an alternative to routine care.

Methods Non-randomised, exploratory study to evaluate Chlamydia-OCCP: 21.07.14 -13.03.15.

Participants: 1) chlamydia-positive untreated Genitourinary Medicine (GUM) clinic attenders; 2) people testing chlamydia-positive and negative through six National Chlamydia Screening Programme (NCSP) areas’ online postal self-sampling service. Exclusions: under 16 yrs; co-existing STIs, extra-genital chlamydia. Intervention: eligible people were sent an SMS message with a link to access results from eSHC via a password protected web-app, optimised for smartphone use. Having consented online chlamydia-positive users followed the automated Chlamydia-OCCP. Patients who declined received routine care.

Evaluation: treatment rate; time to treatment; PN outcomes; engagement with clinical helpline and health promotion; safety; acceptability, costs.

Results GUM: of 197 eligible patients, 161 accessed results online, 112 consented, 110/112 (98%) treated (72 exclusively via Chlamydia-OCCP, median 1 day). NCSP: of 145 eligible patients, 133 accessed results online, 104 consented, 92/104 (88%) treated (59 exclusively via Chlamydia-OCCP, median 1 day).

28/515 sexual partners were managed solely online. 1176/1936, (61%) NCSP chlamydia-negative people accessed results online, of whom 407 accessed online health promotion. All patients who didn’t access results online were managed routinely. Patients moved effectively between online, telephone and clinic-based care.

Conclusion Chlamydia-OCCP is a feasible, acceptable, safe alternative to routine care for management of people with genital chlamydia. Preliminary evidence indicates comparable treatment outcomes. If linked to home testing, Chlamydia-OCCP offers potential for wholly remote care.

Original language	English
Article number	A55
Journal	Sexually Transmitted Infections
Volume	91
Issue number	Supp 2
DOIs	https://doi.org/10.1136/sextrans-2015-052270.153
Publication status	Published - 13 Sept 2015
Externally published	Yes

Access to Document

10.1136/sextrans-2015-052270.153

Cite this

Estcourt, C. S., Gibbs, J., Sutcliffe, L. J., Gkatzidou, V., Tickle, L., Hone, K., Aicken, C., Lowndes, C., Harding-Esch, E. M., Eaton, S., Oakeshott, P., Szczepura, A., Ashcroft, R. E., Hogan, G., Nettleship, A., Pinson, D., Sadiq, SD., & Sonnenberg, P. (2015). Is an automated online clinical care pathway for people with genital chlamydia (chlamydia OCCP) within an eSexual health clinic feasible and acceptable? A proof of concept study. Sexually Transmitted Infections, 91(Supp 2), Article A55. https://doi.org/10.1136/sextrans-2015-052270.153

Is an automated online clinical care pathway for people with genital chlamydia (chlamydia OCCP) within an eSexual health clinic feasible and acceptable? A proof of concept study. / Estcourt, Claudia S; Gibbs, Jo; Sutcliffe, Lorna J et al.
In: Sexually Transmitted Infections, Vol. 91, No. Supp 2, A55, 13.09.2015.

Research output: Contribution to journal › Article › peer-review

Estcourt, CS, Gibbs, J, Sutcliffe, LJ, Gkatzidou, V, Tickle, L, Hone, K, Aicken, C, Lowndes, C, Harding-Esch, EM, Eaton, S, Oakeshott, P, Szczepura, A, Ashcroft, RE, Hogan, G, Nettleship, A, Pinson, D, Sadiq, SD & Sonnenberg, P 2015, 'Is an automated online clinical care pathway for people with genital chlamydia (chlamydia OCCP) within an eSexual health clinic feasible and acceptable? A proof of concept study.', Sexually Transmitted Infections, vol. 91, no. Supp 2, A55. https://doi.org/10.1136/sextrans-2015-052270.153

@article{eca07d488457498cb040af00c0a31d1d,

title = "Is an automated online clinical care pathway for people with genital chlamydia (chlamydia OCCP) within an eSexual health clinic feasible and acceptable? A proof of concept study.",

abstract = "Introduction UK health strategy supports self- and internet-based care. Within the eSTI2 consortium (www.esti2.org.uk) we developed UK{\textquoteright}s first automated Online Clinical Care Pathway for people with genital chlamydia (Chlamydia-OCCP) within an eSexual Health Clinic (eSHC). Chlamydia-OCCP includes: STI results service; clinical consultation; electronic prescription via community pharmacy; partner notification (PN); with integral telephone helpline support. It complies with regulatory, professional, prescribing and surveillance requirements. We report on a study to assess Chlamydia-OCCP feasibility and acceptability as an alternative to routine care.Methods Non-randomised, exploratory study to evaluate Chlamydia-OCCP: 21.07.14 -13.03.15.Participants: 1) chlamydia-positive untreated Genitourinary Medicine (GUM) clinic attenders; 2) people testing chlamydia-positive and negative through six National Chlamydia Screening Programme (NCSP) areas{\textquoteright} online postal self-sampling service. Exclusions: under 16 yrs; co-existing STIs, extra-genital chlamydia. Intervention: eligible people were sent an SMS message with a link to access results from eSHC via a password protected web-app, optimised for smartphone use. Having consented online chlamydia-positive users followed the automated Chlamydia-OCCP. Patients who declined received routine care.Evaluation: treatment rate; time to treatment; PN outcomes; engagement with clinical helpline and health promotion; safety; acceptability, costs.Results GUM: of 197 eligible patients, 161 accessed results online, 112 consented, 110/112 (98%) treated (72 exclusively via Chlamydia-OCCP, median 1 day). NCSP: of 145 eligible patients, 133 accessed results online, 104 consented, 92/104 (88%) treated (59 exclusively via Chlamydia-OCCP, median 1 day).28/515 sexual partners were managed solely online. 1176/1936, (61%) NCSP chlamydia-negative people accessed results online, of whom 407 accessed online health promotion. All patients who didn{\textquoteright}t access results online were managed routinely. Patients moved effectively between online, telephone and clinic-based care.Conclusion Chlamydia-OCCP is a feasible, acceptable, safe alternative to routine care for management of people with genital chlamydia. Preliminary evidence indicates comparable treatment outcomes. If linked to home testing, Chlamydia-OCCP offers potential for wholly remote care.",

author = "Estcourt, {Claudia S} and Jo Gibbs and Sutcliffe, {Lorna J} and Voula Gkatzidou and Laura Tickle and Kate Hone and Catherine Aicken and C Lowndes and Harding-Esch, {Emma M} and Sue Eaton and Pippa Oakeshott and Ala Szczepura and Ashcroft, {Richard E} and G. Hogan and Anthony Nettleship and D Pinson and SD Sadiq and Pam Sonnenberg",

year = "2015",

month = sep,

day = "13",

doi = "10.1136/sextrans-2015-052270.153",

language = "English",

volume = "91",

journal = "Sexually Transmitted Infections",

issn = "1368-4973",

publisher = "BMJ Publishing Group",

number = "Supp 2",

}

TY - JOUR

T1 - Is an automated online clinical care pathway for people with genital chlamydia (chlamydia OCCP) within an eSexual health clinic feasible and acceptable? A proof of concept study.

AU - Estcourt, Claudia S

AU - Gibbs, Jo

AU - Sutcliffe, Lorna J

AU - Gkatzidou, Voula

AU - Tickle, Laura

AU - Hone, Kate

AU - Aicken, Catherine

AU - Lowndes, C

AU - Harding-Esch, Emma M

AU - Eaton, Sue

AU - Oakeshott, Pippa

AU - Szczepura, Ala

AU - Ashcroft, Richard E

AU - Hogan, G.

AU - Nettleship, Anthony

AU - Pinson, D

AU - Sadiq, SD

AU - Sonnenberg, Pam

PY - 2015/9/13

Y1 - 2015/9/13

N2 - Introduction UK health strategy supports self- and internet-based care. Within the eSTI2 consortium (www.esti2.org.uk) we developed UK’s first automated Online Clinical Care Pathway for people with genital chlamydia (Chlamydia-OCCP) within an eSexual Health Clinic (eSHC). Chlamydia-OCCP includes: STI results service; clinical consultation; electronic prescription via community pharmacy; partner notification (PN); with integral telephone helpline support. It complies with regulatory, professional, prescribing and surveillance requirements. We report on a study to assess Chlamydia-OCCP feasibility and acceptability as an alternative to routine care.Methods Non-randomised, exploratory study to evaluate Chlamydia-OCCP: 21.07.14 -13.03.15.Participants: 1) chlamydia-positive untreated Genitourinary Medicine (GUM) clinic attenders; 2) people testing chlamydia-positive and negative through six National Chlamydia Screening Programme (NCSP) areas’ online postal self-sampling service. Exclusions: under 16 yrs; co-existing STIs, extra-genital chlamydia. Intervention: eligible people were sent an SMS message with a link to access results from eSHC via a password protected web-app, optimised for smartphone use. Having consented online chlamydia-positive users followed the automated Chlamydia-OCCP. Patients who declined received routine care.Evaluation: treatment rate; time to treatment; PN outcomes; engagement with clinical helpline and health promotion; safety; acceptability, costs.Results GUM: of 197 eligible patients, 161 accessed results online, 112 consented, 110/112 (98%) treated (72 exclusively via Chlamydia-OCCP, median 1 day). NCSP: of 145 eligible patients, 133 accessed results online, 104 consented, 92/104 (88%) treated (59 exclusively via Chlamydia-OCCP, median 1 day).28/515 sexual partners were managed solely online. 1176/1936, (61%) NCSP chlamydia-negative people accessed results online, of whom 407 accessed online health promotion. All patients who didn’t access results online were managed routinely. Patients moved effectively between online, telephone and clinic-based care.Conclusion Chlamydia-OCCP is a feasible, acceptable, safe alternative to routine care for management of people with genital chlamydia. Preliminary evidence indicates comparable treatment outcomes. If linked to home testing, Chlamydia-OCCP offers potential for wholly remote care.

AB - Introduction UK health strategy supports self- and internet-based care. Within the eSTI2 consortium (www.esti2.org.uk) we developed UK’s first automated Online Clinical Care Pathway for people with genital chlamydia (Chlamydia-OCCP) within an eSexual Health Clinic (eSHC). Chlamydia-OCCP includes: STI results service; clinical consultation; electronic prescription via community pharmacy; partner notification (PN); with integral telephone helpline support. It complies with regulatory, professional, prescribing and surveillance requirements. We report on a study to assess Chlamydia-OCCP feasibility and acceptability as an alternative to routine care.Methods Non-randomised, exploratory study to evaluate Chlamydia-OCCP: 21.07.14 -13.03.15.Participants: 1) chlamydia-positive untreated Genitourinary Medicine (GUM) clinic attenders; 2) people testing chlamydia-positive and negative through six National Chlamydia Screening Programme (NCSP) areas’ online postal self-sampling service. Exclusions: under 16 yrs; co-existing STIs, extra-genital chlamydia. Intervention: eligible people were sent an SMS message with a link to access results from eSHC via a password protected web-app, optimised for smartphone use. Having consented online chlamydia-positive users followed the automated Chlamydia-OCCP. Patients who declined received routine care.Evaluation: treatment rate; time to treatment; PN outcomes; engagement with clinical helpline and health promotion; safety; acceptability, costs.Results GUM: of 197 eligible patients, 161 accessed results online, 112 consented, 110/112 (98%) treated (72 exclusively via Chlamydia-OCCP, median 1 day). NCSP: of 145 eligible patients, 133 accessed results online, 104 consented, 92/104 (88%) treated (59 exclusively via Chlamydia-OCCP, median 1 day).28/515 sexual partners were managed solely online. 1176/1936, (61%) NCSP chlamydia-negative people accessed results online, of whom 407 accessed online health promotion. All patients who didn’t access results online were managed routinely. Patients moved effectively between online, telephone and clinic-based care.Conclusion Chlamydia-OCCP is a feasible, acceptable, safe alternative to routine care for management of people with genital chlamydia. Preliminary evidence indicates comparable treatment outcomes. If linked to home testing, Chlamydia-OCCP offers potential for wholly remote care.

U2 - 10.1136/sextrans-2015-052270.153

DO - 10.1136/sextrans-2015-052270.153

M3 - Article

SN - 1368-4973

VL - 91

JO - Sexually Transmitted Infections

JF - Sexually Transmitted Infections

IS - Supp 2

M1 - A55

ER -

Is an automated online clinical care pathway for people with genital chlamydia (chlamydia OCCP) within an eSexual health clinic feasible and acceptable? A proof of concept study.

Abstract

Access to Document

Fingerprint

Cite this